highly significantP <0.001
At 12 months, APΔE9 mice reached the goal arm only 50% of the trials compared with 70% for the WT controls, reaching statistical significance ( P <0.01), while the APΔE9/RanBP9 triple-transgenic mice made correct choices only 34% of the times, which was also highly significant ( P <0.001).